DERON RICKS: Open Payments
NPI 1639156573 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 48 payments from 21 companies in 2025. Trend: 2023 $497 · 2024 $1,032 · 2025 $921
Food & beverage: $921
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $174 |
| ABBVIE INC. | 10 | $152 |
| Lilly USA, LLC | 4 | $63 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Novo Nordisk Inc | 3 | $53 |
| Phathom Pharmaceuticals, Inc. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Astellas Pharma US Inc | 1 | $34 |
| PFIZER INC. | 2 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
Products named: FANAPT, VRAYLAR, Auvelity, VOQUEZNA, QULIPTA, MOUNJARO, REXULTI, Veozah.
Industry payments across ID — which companies pay providers there.
